BetterLife Pharma (BETRF) Change in Accured Expenses (2010 - 2026)

BetterLife Pharma's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $2357.8 for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 93.05% year-over-year to $2357.8; the TTM figure through Apr 2026 stood at -$301699.8 (up 43.72% YoY), while the FY2023 annual figure was $1.7 million, up 283.23% from the prior year.
• Change in Accured Expenses for Q2 2026 stood at $2357.8, down from $11650.4 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.1 million in Q2 2022, with the low at -$550488.2 in Q2 2023.
• The 5-year median for Change in Accured Expenses is $40336.4 (2023), against an average of $55673.7.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 1390.29% in 2023, then sank 848.29% in 2024.
• BetterLife Pharma's Change in Accured Expenses stood at -$216621.6 in 2022, then soared by 121.57% to $46726.9 in 2023, then tumbled by 848.29% to -$349653.9 in 2024, then jumped by 103.33% to $11650.4 in 2025, then slumped by 79.76% to $2357.8 in 2026.
• Business Quant data shows BETRF's Change in Accured Expenses at $2357.8 in Q2 2026, $11650.4 in Q3 2025, and $33946.0 in Q2 2025.